1. Home
  2. NNBR vs VNDA Comparison

NNBR vs VNDA Comparison

Compare NNBR & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NN Inc.

NNBR

NN Inc.

N/A

Current Price

$3.95

Market Cap

318.8M

Sector

Industrials

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$4.57

Market Cap

301.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NNBR
VNDA
Founded
1980
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
318.8M
301.1M
IPO Year
1996
2005

Fundamental Metrics

Financial Performance
Metric
NNBR
VNDA
Price
$3.95
$4.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$6.67
★ $11.75
AVG Volume (30 Days)
★ 2.2M
778.6K
Earning Date
10-28-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 3.60
N/A
EPS
★ N/A
N/A
Revenue
★ $770,657,000.00
$216,105,000.00
Revenue This Year
$13.55
$15.16
Revenue Next Year
$8.08
$35.50
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 8.72
52 Week Low
$1.10
$4.27
52 Week High
$4.59
$9.91

Technical Indicators

Market Signals
Indicator
NNBR
VNDA
Relative Strength Index (RSI) 54.21 33.10
Support Level $3.40 $4.45
Resistance Level $4.45 $5.37
Average True Range (ATR) 0.25 0.17
MACD 0.03 -0.04
Stochastic Oscillator 46.24 20.92

Price Performance

Historical Comparison
NNBR
VNDA

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: